Axios

@axios ↗

Deleted No

Hibernated Yes

Last Checked Oct. 26, 2022

Created

Fri Sep 02 18:42:35 +0000 2022

Likes

145

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

Axios @axios

Paxlovid could have the added benefit of warding off long COVID, or symptoms that linger beyond the first 30 days after testing positive, and studies to determine this are underway. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated

Preceded By

Axios @axios

The prospect of reinfection shouldn't discourage older or high-risk patients from taking the pills, said Yale infectious diseases specialist Scott Roberts. "Rebound is almost always more mild than initial course," Roberts told Axios. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated

Followed By

Axios @axios

COVID rebound has also been observed in people who have not taken Paxlovid, and some experts believe it might be a natural course of the infection to see symptoms ebb, then return. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated